Associated Papers
Developing a more accurate population frequency of Marfan syndrome from predicted pathogenic FBN1 variants in the gnomAD cohorts.
Choi K et al.
Scientific Reports, 2025
40102521 (PubMed )
Supplement: 41598_2025_93832_MOESM1_ESM.xlsx › FBN1
Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections.
Ponińska JK et al.
Journal of Translational Medicine, 2022
35078481 (PubMed )
Supplement: 12967_2022_3251_MOESM1_ESM.pdf
Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations.
Poninska JK et al.
Journal of Translational Medicine, 2016
Ehlers-Danlos syndrome type IV is associated with a novel G984R COL3A1 mutation.
Deng Y et al.
Molecular Medicine Reports, 2015
Achieving high-sensitivity for clinical applications using augmented exome sequencing.
Patwardhan A et al.
Genome Medicine, 2015
26269718 (PubMed )
Supplement: 13073_2015_197_MOESM8_ESM.xlsx › Sheet1
Multiplex targeted high-throughput sequencing for Mendelian cardiac disorders.
Fokstuen S et al.
Clinical Genetics, 2014
A new novel mutation in FBN1 causes autosomal dominant Marfan syndrome in a Chinese family.
Dong J et al.
Molecular Vision, 2012
TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies.
Katzke S et al.
Human Mutation, 2002
A novel mutation in the neonatal region of the fibrillin (FBN)1 gene associated with a classical phenotype of Marfan syndrome (MfS). Mutations in brief no. 163. Online.
Grau U et al.
Human Mutation, 1998
Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils.
Yuan X et al.
The Embo Journal, 1997
Select a paper to view details